Evidence map›Paper›PMID 38132270›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level.

Marita Restie Tiara, Hofiya Djauhari, Febi Ramdhani Rachman, Antonius Christianus Rettob, Darmastuti Utami, Fahda Cintia Suci Pulungan, Heru Purwanta, Rudi Wisaksana, Bachti Alisjahbana, Agnes Rengga Indrati

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marita Restie TiaraResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Hofiya DjauhariResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Febi Ramdhani RachmanResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Antonius Christianus RettobResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Darmastuti UtamiResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Fahda Cintia Suci PulunganResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Heru PurwantaResearch Center for Agroindustry-National Research and Innovation Agency (BRIN), Jakarta 16911, DKI Jakarta, Indonesia.
Rudi WisaksanaResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.
Bachti AlisjahbanaResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.ORCID 0000-0003-3745-8229
Agnes Rengga IndratiResearch Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung 40161, West Java, Indonesia.ORCID 0000-0003-3923-9767

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative determination of anti-SARS-CoV2-S-RBD is necessary for the evaluation of vaccination effectiveness. The surrogate viral neutralization test (SVNT) is approved for measuring anti-SARS-CoV2-S-RBD, but a point-of-care platform is needed to simplify anti-SARS-CoV-2-S-RBD measurement. We aimed to evaluate the performance of a rapid fluorescent immunoassay-based kit, FastBio-RBD

Indexed as

antibodyCOVID-19immunoassayvaccination

Identifiers

PMID38132270
PMCPMC10743294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.